During the past recent years, various therapies emerged in the era of breast cancer. Breast
cancer is a heterogeneous disease in which genetic and environmental factors are involved …

Breast cancer is the most prevalent cancer among women worldwide. However, increased
survival is due to the dramatic advances in the screening methods, early diagnosis, and …

Breast cancer is the second leading cause of death for women worldwide. The
heterogeneity of this disease presents a big challenge in its therapeutic management …

Breast cancer (BC) is one of the prevalent cancers among women. Generally, the treatment
of BC is mostly based on several prominent strategies, including chemotherapy, surgery …

Breast cancer is the most commonly diagnosed cancer among women. Therapeutic
treatments for breast cancer generally include surgery, chemotherapy, radiotherapy …

Breast cancer (BC) is one of the most widely diagnosed cancers and a leading cause of
cancer death among women worldwide. Globally, BC is the second most frequent cancer …

Breast cancer is the most commonly diagnosed cancer type and the leading cause of cancer-
related mortality in women worldwide. Breast cancer is fairly heterogeneous and reveals six …

Antibody drug conjugates (ADCs) are novel medications that combine monoclonal
antibodies with cytotoxic payloads, enabling the selective delivery of potent drugs to cancer …

Breast cancer is categorized at the molecular level according to the status of certain
hormone and growth factor receptors, and this classification forms the basis of current …

Breast cancer is the most common malignant disease in women worldwide, but the current
drug therapy is far from optimal as indicated by the high death rate of breast cancer patients …